Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discovery.

Haghighi A, Krier JB, Toth-Petroczy A, Cassa CA, Frank NY, Carmichael N, Fieg E, Bjonnes A, Mohanty A, Briere LC, Lincoln S, Lucia S, Gupta VA, Söylemez O, Sutti S, Kooshesh K, Qiu H, Fay CJ, Perroni V, Valerius J, Hanna M, Frank A, Ouahed J, Snapper SB, Pantazi A, Chopra SS, Leshchiner I, Stitziel NO, Feldweg A, Mannstadt M, Loscalzo J, Sweetser DA, Liao E, Stoler JM, Nowak CB, Sanchez-Lara PA, Klein OD, Perry H, Patsopoulos NA, Raychaudhuri S, Goessling W, Green RC, Seidman CE, MacRae CA, Sunyaev SR, Maas RL, Vuzman D; Undiagnosed Diseases Network, Brigham and Women’s Hospital FaceBase Project, Brigham Genomic Medicine (BGM).

NPJ Genom Med. 2018 Aug 13;3:21. doi: 10.1038/s41525-018-0060-9. eCollection 2018. Review.

2.

B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).

Bruzzì S, Sutti S, Giudici G, Burlone ME, Ramavath NN, Toscani A, Bozzola C, Schneider P, Morello E, Parola M, Pirisi M, Albano E.

Free Radic Biol Med. 2018 Aug 20;124:249-259. doi: 10.1016/j.freeradbiomed.2018.06.015. Epub 2018 Jun 18.

3.

Liver inflammation and regeneration in drug-induced liver injury: sex matters!

Sutti S, Tacke F.

Clin Sci (Lond). 2018 Mar 15;132(5):609-613. doi: 10.1042/CS20171313. Print 2018 Mar 15.

PMID:
29545336
4.

Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein.

Morello E, Sutti S, Foglia B, Novo E, Cannito S, Bocca C, Rajsky M, Bruzzì S, Abate ML, Rosso C, Bozzola C, David E, Bugianesi E, Albano E, Parola M.

Hepatology. 2018 Jun;67(6):2196-2214. doi: 10.1002/hep.29754. Epub 2018 Apr 19.

5.

Notch signaling and progenitor/ductular reaction in steatohepatitis.

Morell CM, Fiorotto R, Meroni M, Raizner A, Torsello B, Cadamuro M, Spagnuolo G, Kaffe E, Sutti S, Albano E, Strazzabosco M.

PLoS One. 2017 Nov 15;12(11):e0187384. doi: 10.1371/journal.pone.0187384. eCollection 2017.

6.

CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury.

Sutti S, Heymann F, Bruzzì S, Peusquens J, Trautwein C, Albano E, Tacke F.

Clin Sci (Lond). 2017 Jul 24. pii: CS20171025. doi: 10.1042/CS20171025. [Epub ahead of print]

PMID:
28739980
7.

SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells.

Novo E, Villano G, Turato C, Cannito S, Paternostro C, Busletta C, Biasiolo A, Quarta S, Morello E, Bocca C, Miglietta A, David E, Sutti S, Plebani M, Albano E, Parola M, Pontisso P.

Sci Rep. 2017 Jun 13;7(1):3420. doi: 10.1038/s41598-017-03744-3.

8.

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.

Cannito S, Morello E, Bocca C, Foglia B, Benetti E, Novo E, Chiazza F, Rogazzo M, Fantozzi R, Povero D, Sutti S, Bugianesi E, Feldstein AE, Albano E, Collino M, Parola M.

PLoS One. 2017 Mar 1;12(3):e0172575. doi: 10.1371/journal.pone.0172575. eCollection 2017.

9.

Early life adversity alters normal sex-dependent developmental dynamics of DNA methylation.

Massart R, Nemoda Z, Suderman MJ, Sutti S, Ruggiero AM, Dettmer AM, Suomi SJ, Szyf M.

Dev Psychopathol. 2016 Nov;28(4pt2):1259-1272. Epub 2016 Sep 30.

PMID:
27687908
10.

The Signature of Maternal Social Rank in Placenta Deoxyribonucleic Acid Methylation Profiles in Rhesus Monkeys.

Massart R, Suderman MJ, Nemoda Z, Sutti S, Ruggiero AM, Dettmer AM, Suomi SJ, Szyf M.

Child Dev. 2017 May;88(3):900-918. doi: 10.1111/cdev.12640. Epub 2016 Oct 14.

11.

The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.

Mez J, Mukherjee S, Thornton T, Fardo DW, Trittschuh E, Sutti S, Sherva R, Kauwe JS, Naj AC, Beecham GW, Gross A, Saykin AJ, Green RC, Crane PK; Executive Prominent Alzheimer's Disease: Genetics and Risk Factors (EPAD:GRF); Alzheimer's Disease Neuroimaging Initiative (ADNI1); Alzheimer's Disease Genetics Consortium (ADGC).

Neurobiol Aging. 2016 May;41:115-121. doi: 10.1016/j.neurobiolaging.2016.02.015. Epub 2016 Feb 21.

12.

"Big Data" Gets Personal.

Lebo MS, Sutti S, Green RC.

Sci Transl Med. 2016 Jan 20;8(322):322fs3-3fs3. doi: 10.1126/scitranslmed.aad9460. Review.

PMID:
26791946
13.

The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.

Sutti S, Bruzzì S, Albano E.

Expert Rev Gastroenterol Hepatol. 2016;10(2):243-53. doi: 10.1586/17474124.2016.1111758. Epub 2015 Dec 3. Review.

PMID:
26634783
14.

CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis.

Sutti S, Locatelli I, Bruzzì S, Jindal A, Vacchiano M, Bozzola C, Albano E.

Clin Sci (Lond). 2015 Nov;129(9):797-808. doi: 10.1042/CS20150053. Epub 2015 Jun 25.

PMID:
26253086
15.

Is there a role for adaptive immunity in nonalcoholic steatohepatitis?

Sutti S, Jindal A, Bruzzì S, Locatelli I, Bozzola C, Albano E.

World J Hepatol. 2015 Jul 8;7(13):1725-9. doi: 10.4254/wjh.v7.i13.1725.

16.

Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).

Jindal A, Bruzzì S, Sutti S, Locatelli I, Bozzola C, Paternostro C, Parola M, Albano E.

Exp Mol Pathol. 2015 Aug;99(1):155-62. doi: 10.1016/j.yexmp.2015.06.015. Epub 2015 Jun 22.

17.

CYP2E1 autoantibodies in liver diseases.

Sutti S, Rigamonti C, Vidali M, Albano E.

Redox Biol. 2014;3:72-8. doi: 10.1016/j.redox.2014.11.004. Epub 2014 Nov 18. Review.

18.

Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice.

Locatelli I, Sutti S, Jindal A, Vacchiano M, Bozzola C, Reutelingsperger C, Kusters D, Bena S, Parola M, Paternostro C, Bugianesi E, McArthur S, Albano E, Perretti M.

Hepatology. 2014 Aug;60(2):531-44. doi: 10.1002/hep.27141. Epub 2014 May 12.

19.

Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.

Sutti S, Jindal A, Locatelli I, Vacchiano M, Gigliotti L, Bozzola C, Albano E.

Hepatology. 2014 Mar;59(3):886-97. doi: 10.1002/hep.26749. Epub 2014 Jan 16.

PMID:
24115128
20.

NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.

Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E.

Clin Sci (Lond). 2013 Feb;124(4):279-87. doi: 10.1042/CS20120289.

PMID:
22970906
21.

Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.

Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, Vizzutti F, Sutti S, Locatelli I, Navari N, Vivoli E, Caligiuri A, Pinzani M, Albano E, Parola M, Marra F.

Clin Sci (Lond). 2012 Oct;123(7):459-71. doi: 10.1042/CS20110515.

22.

Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.

Imarisio C, Alchera E, Sutti S, Valente G, Boccafoschi F, Albano E, Carini R.

Clin Sci (Lond). 2012 Sep;123(5):323-32. doi: 10.1042/CS20110504.

PMID:
22439844
23.

Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.

Maina V, Sutti S, Locatelli I, Vidali M, Mombello C, Bozzola C, Albano E.

Clin Sci (Lond). 2012 Jun;122(11):545-53. doi: 10.1042/CS20110366.

PMID:
22142284
24.

Oxidative stress parameters in paediatric non-alcoholic fatty liver disease.

Nobili V, Parola M, Alisi A, Marra F, Piemonte F, Mombello C, Sutti S, Povero D, Maina V, Novo E, Albano E.

Int J Mol Med. 2010 Oct;26(4):471-6.

PMID:
20818484
25.

Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C.

Sutti S, Vidali M, Mombello C, Sartori M, Albano E.

J Viral Hepat. 2010 Oct;17(10):685-90. doi: 10.1111/j.1365-2893.2010.01359.x.

PMID:
20738774
26.

Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry.

Sutti S, Vidali M, Mombello C, Sartori M, Ingelman-Sundberg M, Albano E.

J Hepatol. 2010 Sep;53(3):431-8. doi: 10.1016/j.jhep.2010.03.030. Epub 2010 May 31.

PMID:
20576306
27.

Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C.

Rigamonti C, Vidali M, Donato MF, Sutti S, Occhino G, Ivaldi A, Arosio E, Agnelli F, Rossi G, Colombo M, Albano E.

Am J Transplant. 2009 Mar;9(3):601-9. doi: 10.1111/j.1600-6143.2008.02520.x. Epub 2009 Feb 3.

28.

Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers.

Vidali M, Hietala J, Occhino G, Ivaldi A, Sutti S, Niemelä O, Albano E.

Free Radic Biol Med. 2008 Aug 1;45(3):306-11. doi: 10.1016/j.freeradbiomed.2008.04.012. Epub 2008 Apr 18.

PMID:
18460346
29.

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE.

J Hepatol. 2008 Mar;48(3):399-406. doi: 10.1016/j.jhep.2007.10.011. Epub 2007 Dec 3.

PMID:
18164507

Supplemental Content

Support Center